ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,434,725 | +7.9% | 145,276 | 0.0% | 0.51% | +20.0% |
| Q2 2023 | $7,820,207 | -35.7% | 145,276 | -52.6% | 0.42% | -41.0% |
| Q1 2023 | $12,165,322 | -8.8% | 306,277 | -7.7% | 0.72% | -13.0% |
| Q4 2022 | $13,343,929 | +22.7% | 331,691 | -2.0% | 0.83% | +20.2% |
| Q3 2022 | $10,876,000 | +2.7% | 338,398 | -5.2% | 0.69% | +11.9% |
| Q2 2022 | $10,588,000 | +25.8% | 356,865 | +19.2% | 0.61% | +65.1% |
| Q1 2022 | $8,419,000 | +104.1% | 299,493 | +234.7% | 0.37% | +156.6% |
| Q4 2021 | $4,124,000 | +40.0% | 89,491 | -14.1% | 0.14% | -48.6% |
| Q3 2014 | $2,945,000 | -17.9% | 104,134 | 0.0% | 0.28% | -14.5% |
| Q2 2014 | $3,586,000 | +83.7% | 104,134 | +67.2% | 0.33% | +76.5% |
| Q1 2014 | $1,952,000 | – | 62,277 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |